BIOLASE (NASDAQ:BIOL) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a report issued on Thursday morning. The firm issued a sell rating on the medical technology company’s stock.

A number of other equities analysts have also recently issued reports on BIOL. Benchmark restated a speculative buy rating and set a $0.40 price target on shares of BIOLASE in a report on Wednesday. Ascendiant Capital Markets cut their target price on shares of BIOLASE from $3.50 to $2.00 and set a buy rating on the stock in a research note on Tuesday, September 3rd.

BIOLASE Price Performance

BIOL opened at $0.02 on Thursday. BIOLASE has a twelve month low of $0.02 and a twelve month high of $1.94. The company has a fifty day moving average of $0.06 and a 200-day moving average of $0.11. The stock has a market cap of $501,105.00, a PE ratio of 0.00 and a beta of 0.67.

BIOLASE (NASDAQ:BIOL) last posted its quarterly earnings data on Thursday, August 8th. The medical technology company reported ($0.08) earnings per share for the quarter. The business had revenue of $11.56 million during the quarter. BIOLASE had a negative return on equity of 1,782.73% and a negative net margin of 41.65%.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC lifted its position in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 143,537 shares of the medical technology company’s stock after purchasing an additional 131,248 shares during the quarter. Virtu Financial LLC owned 0.43% of BIOLASE worth $27,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 8.79% of the company’s stock.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.